Mammary-type Myofibroblastoma with Leiomyomatous Differentiation: A Rare Variant with Potential Pitfalls

Int J Surg Pathol. 2022 Apr;30(2):200-206. doi: 10.1177/10668969211031309. Epub 2021 Aug 2.

Abstract

Myofibroblastoma is a rare, benign stromal tumor with a diverse morphologic spectrum. Mammary-type myofibroblastoma (MTMF) is the extra-mammary counterpart of this neoplasm and its occurrence throughout the body has become increasingly recognized. Similar morphologic variations of MTMF have now been described which mirror those seen in the breast. We describe a case of intra-abdominal MTMF composed of short fascicles of eosinophilic spindle cells admixed with mature adipose tissue. The spindle cells stained diffusely positive for CD34, desmin, smooth muscle actin, and h-caldesmon by immunohistochemistry. Concurrent loss of RB1 (13q14) and 13q34 loci were confirmed by fluorescence in situ hybridization whereas anchored multiplex PCR and whole transcriptome sequencing did not reveal any pathognomonic fusions suggesting an alternative diagnosis. To the best of our knowledge this is the first documented case of leiomyomatous variant of MTMF.

Keywords: leiomyomatous differentiation; mammary-type myofibroblastoma.

Publication types

  • Case Reports

MeSH terms

  • Biomarkers, Tumor / analysis
  • Humans
  • Immunohistochemistry
  • In Situ Hybridization, Fluorescence
  • Leiomyoma* / diagnosis
  • Leiomyoma* / pathology
  • Neoplasms, Muscle Tissue* / diagnosis
  • Neoplasms, Muscle Tissue* / genetics
  • Neoplasms, Muscle Tissue* / pathology

Substances

  • Biomarkers, Tumor